Saamya Biotech (India) Limited reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2016. For the quarter, the company reported profit from operations from other income, interest and exceptional items were INR 3,129,285 against INR 2,756,612 a year ago. Loss from ordinary activities before and after tax was INR 3,132,489 against INR 1,782,474 a year ago. Net loss for the period was INR 3,132,489 against INR 1,782,474 a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.13 against INR of 0.07 a year ago. For the six months, the company reported profit from operations from other income, interest and exceptional items were INR 5,695,341 against INR 5,148,266 a year ago. Loss from ordinary activities before and after tax was INR 5,701,608 against INR 4,190,674 a year ago. Net loss for the period was INR 5,701,608 against INR 4,190,674 a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.23 against INR of 0.17 a year ago.